Clinical Trials for Leiomyosarcoma New clinical trials come up depending on what cancer researchers are working on. Some of the current ones for leiomyosarcoma are for a type of treatment called ...

Uterine leiomyosarcoma is a rare and aggressive cancer that occurs in the uterus. Individuals usually require a hysterectomy. Treatments can also include chemotherapy or radiotherapy. Leiomyosarcoma ...

Uterine leiomyosarcoma is a rare form of cancer. The earlier uterine leiomyosarcoma is diagnosed, the better the outlook. Uterine leiomyosarcoma accounts for 2–5% of all uterine cancers. It starts in ...

Once your treatment is done, your oncologist may tell you that your leiomyosarcoma is in “remission.” This means that signs of your cancer have faded or disappeared. But that doesn’t mean you’re ...

DelveInsight’s, “Leiomyosarcoma Pipeline Insight” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Leiomyosarcoma pipeline landscape. It covers the Leiomyosarcoma ...

YouTube star Luke Goodwin passed away on August 2, 2024, at the age of 35. He was battling a rare form of cancer called Leiomyosarcoma for around two years, which eventually led to his demise. The ...

Soft Tissue and Uterine Leiomyosarcoma The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held ...

The antitumor drug trabectedin demonstrated superior disease control compared with conventional chemotherapy among patients with advanced liposarcoma and leiomyosarcoma who failed after prior ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A 45-year-old woman reported she had ...

A randomized phase III trial of catequentinib hydrochloride (AL3818) versus placebo in subjects with metastatic or advanced leiomyosarcoma (LMS). This is an ASCO Meeting Abstract from the 2025 ASCO ...

Background: Leiomyosarcoma is a rare malignant mesenchymal tumor that represents 5–7 % of all soft tissue sarcomas. The occurrence of this tumor in the salivary glands is exceptional. Only five cases ...

Editor's Note: Uterine leiomyosarcomas are aggressive, heterogeneous cancers associated with high rates of progression and recurrence—and poor outcome. Uterine sarcomas as a group are uncommon cancers ...